Epileptic Seizures Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: E514B370D029EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Epileptic Seizures Treatment in Global, including the following market information:

Global Epileptic Seizures Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Epileptic Seizures Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epileptic Seizures Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Epileptic Seizures Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Epileptic Seizures Treatment Market Segment Percentages, By Type, 2020 (%)

• Treatment Practices
• Emerging Drugs
• Individual Therapies

China Epileptic Seizures Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Epileptic Seizures Treatment Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Others

Global Epileptic Seizures Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Epileptic Seizures Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Epileptic Seizures Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Epileptic Seizures Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Bausch Health Companies, Inc.
• GlaxoSmithKline plc.
• UCB S.A.
• Pfizer, Inc.
• Apotex, Inc.
• Alexza Pharmaceuticals, Inc.
• Neurelis, Inc.
• Veriton Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Developmental and Epileptic Encephalopathies (DEE) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Developmental and Epileptic Encephalopathies (DEE) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEE) OVERALL MARKET SIZE

2.1 Global Developmental and Epileptic Encephalopathies (DEE) Market Size: 2021 VS 2027
2.2 Global Developmental and Epileptic Encephalopathies (DEE) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Developmental and Epileptic Encephalopathies (DEE) Players in Global Market
3.2 Top Global Developmental and Epileptic Encephalopathies (DEE) Companies Ranked by Revenue
3.3 Global Developmental and Epileptic Encephalopathies (DEE) Revenue by Companies
3.4 Top 3 and Top 5 Developmental and Epileptic Encephalopathies (DEE) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Developmental and Epileptic Encephalopathies (DEE) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Developmental and Epileptic Encephalopathies (DEE) Players in Global Market
  3.6.1 List of Global Tier 1 Developmental and Epileptic Encephalopathies (DEE) Companies
  3.6.2 List of Global Tier 2 and Tier 3 Developmental and Epileptic Encephalopathies (DEE) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Developmental and Epileptic Encephalopathies (DEE) Market Size Markets, 2021 & 2027
  4.1.2 Atypical Benign Partial Epilepsy of Childhood
  4.1.3 Dravet Syndrome
  4.1.4 Epilepsy with Continuous Spike-and -Waves during Slow-Wave Sleep
  4.1.5 Hypothalamic Epilepsy
  4.1.6 Landau-Kleffner Syndrome (LKS)
  4.1.7 Lennox-Gastaut Syndrome
  4.1.8 Myoclonic Status in Non-Progressive Encephalopathies
  4.1.9 West Syndrome
4.2 By Type - Global Developmental and Epileptic Encephalopathies (DEE) Revenue & Forecasts
  4.2.1 By Type - Global Developmental and Epileptic Encephalopathies (DEE) Revenue, 2016-2021
  4.2.2 By Type - Global Developmental and Epileptic Encephalopathies (DEE) Revenue, 2022-2027
  4.2.3 By Type - Global Developmental and Epileptic Encephalopathies (DEE) Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Developmental and Epileptic Encephalopathies (DEE) Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Developmental and Epileptic Encephalopathies (DEE) Revenue & Forecasts
  5.2.1 By Application - Global Developmental and Epileptic Encephalopathies (DEE) Revenue, 2016-2021
  5.2.2 By Application - Global Developmental and Epileptic Encephalopathies (DEE) Revenue, 2022-2027
  5.2.3 By Application - Global Developmental and Epileptic Encephalopathies (DEE) Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Developmental and Epileptic Encephalopathies (DEE) Market Size, 2021 & 2027
6.2 By Region - Global Developmental and Epileptic Encephalopathies (DEE) Revenue & Forecasts
  6.2.1 By Region - Global Developmental and Epileptic Encephalopathies (DEE) Revenue, 2016-2021
  6.2.2 By Region - Global Developmental and Epileptic Encephalopathies (DEE) Revenue, 2022-2027
  6.2.3 By Region - Global Developmental and Epileptic Encephalopathies (DEE) Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Developmental and Epileptic Encephalopathies (DEE) Revenue, 2016-2027
  6.3.2 US Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.3.3 Canada Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.3.4 Mexico Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Developmental and Epileptic Encephalopathies (DEE) Revenue, 2016-2027
  6.4.2 Germany Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.4.3 France Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.4.4 U.K. Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.4.5 Italy Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.4.6 Russia Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.4.7 Nordic Countries Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.4.8 Benelux Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Developmental and Epileptic Encephalopathies (DEE) Revenue, 2016-2027
  6.5.2 China Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.5.3 Japan Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.5.4 South Korea Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.5.5 Southeast Asia Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.5.6 India Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Developmental and Epileptic Encephalopathies (DEE) Revenue, 2016-2027
  6.6.2 Brazil Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.6.3 Argentina Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Developmental and Epileptic Encephalopathies (DEE) Revenue, 2016-2027
  6.7.2 Turkey Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.7.3 Israel Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.7.4 Saudi Arabia Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027
  6.7.5 UAE Developmental and Epileptic Encephalopathies (DEE) Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Biocodex
  7.1.1 Biocodex Corporate Summary
  7.1.2 Biocodex Business Overview
  7.1.3 Biocodex Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.1.4 Biocodex Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.1.5 Biocodex Key News
7.2 Bio-Pharm Solutions
  7.2.1 Bio-Pharm Solutions Corporate Summary
  7.2.2 Bio-Pharm Solutions Business Overview
  7.2.3 Bio-Pharm Solutions Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.2.4 Bio-Pharm Solutions Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.2.5 Bio-Pharm Solutions Key News
7.3 Eisai Pharmaceuticals
  7.3.1 Eisai Pharmaceuticals Corporate Summary
  7.3.2 Eisai Pharmaceuticals Business Overview
  7.3.3 Eisai Pharmaceuticals Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.3.4 Eisai Pharmaceuticals Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.3.5 Eisai Pharmaceuticals Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.4.4 GlaxoSmithKline Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.4.5 GlaxoSmithKline Key News
7.5 Greenwich Biosciences
  7.5.1 Greenwich Biosciences Corporate Summary
  7.5.2 Greenwich Biosciences Business Overview
  7.5.3 Greenwich Biosciences Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.5.4 Greenwich Biosciences Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.5.5 Greenwich Biosciences Key News
7.6 Janssen Pharmaceuticals
  7.6.1 Janssen Pharmaceuticals Corporate Summary
  7.6.2 Janssen Pharmaceuticals Business Overview
  7.6.3 Janssen Pharmaceuticals Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.6.4 Janssen Pharmaceuticals Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.6.5 Janssen Pharmaceuticals Key News
7.7 Lundbeck
  7.7.1 Lundbeck Corporate Summary
  7.7.2 Lundbeck Business Overview
  7.7.3 Lundbeck Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.4.4 Lundbeck Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.7.5 Lundbeck Key News
7.8 Mylan Pharmaceuticals
  7.8.1 Mylan Pharmaceuticals Corporate Summary
  7.8.2 Mylan Pharmaceuticals Business Overview
  7.8.3 Mylan Pharmaceuticals Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.8.4 Mylan Pharmaceuticals Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.8.5 Mylan Pharmaceuticals Key News
7.9 PTC Therapeutics
  7.9.1 PTC Therapeutics Corporate Summary
  7.9.2 PTC Therapeutics Business Overview
  7.9.3 PTC Therapeutics Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.9.4 PTC Therapeutics Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.9.5 PTC Therapeutics Key News
7.10 Roche
  7.10.1 Roche Corporate Summary
  7.10.2 Roche Business Overview
  7.10.3 Roche Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.10.4 Roche Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.10.5 Roche Key News
7.11 Takeda Pharmaceutical
  7.11.1 Takeda Pharmaceutical Corporate Summary
  7.11.2 Takeda Pharmaceutical Business Overview
  7.11.3 Takeda Pharmaceutical Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.11.4 Takeda Pharmaceutical Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.11.5 Takeda Pharmaceutical Key News
7.12 Zogenix
  7.12.1 Zogenix Corporate Summary
  7.12.2 Zogenix Business Overview
  7.12.3 Zogenix Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.12.4 Zogenix Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.12.5 Zogenix Key News
7.13 Zynerba Pharma
  7.13.1 Zynerba Pharma Corporate Summary
  7.13.2 Zynerba Pharma Business Overview
  7.13.3 Zynerba Pharma Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.13.4 Zynerba Pharma Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.13.5 Zynerba Pharma Key News
7.14 Ovid Therapeutics
  7.14.1 Ovid Therapeutics Corporate Summary
  7.14.2 Ovid Therapeutics Business Overview
  7.14.3 Ovid Therapeutics Developmental and Epileptic Encephalopathies (DEE) Major Product Offerings
  7.14.4 Ovid Therapeutics Developmental and Epileptic Encephalopathies (DEE) Revenue in Global (2016-2021)
  7.14.5 Ovid Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Epileptic Seizures Treatment Market Opportunities & Trends in Global Market
Table 2. Epileptic Seizures Treatment Market Drivers in Global Market
Table 3. Epileptic Seizures Treatment Market Restraints in Global Market
Table 4. Key Players of Epileptic Seizures Treatment in Global Market
Table 5. Top Epileptic Seizures Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Epileptic Seizures Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Epileptic Seizures Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Epileptic Seizures Treatment Product Type
Table 9. List of Global Tier 1 Epileptic Seizures Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epileptic Seizures Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Epileptic Seizures Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Epileptic Seizures Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Epileptic Seizures Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Epileptic Seizures Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Epileptic Seizures Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Epileptic Seizures Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Epileptic Seizures Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Epileptic Seizures Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Epileptic Seizures Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Epileptic Seizures Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Epileptic Seizures Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Epileptic Seizures Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Epileptic Seizures Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Epileptic Seizures Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Bausch Health Companies, Inc. Corporate Summary
Table 31. Bausch Health Companies, Inc. Epileptic Seizures Treatment Product Offerings
Table 32. Bausch Health Companies, Inc. Epileptic Seizures Treatment Revenue (US$, Mn), (2016-2021)
Table 33. GlaxoSmithKline plc. Corporate Summary
Table 34. GlaxoSmithKline plc. Epileptic Seizures Treatment Product Offerings
Table 35. GlaxoSmithKline plc. Epileptic Seizures Treatment Revenue (US$, Mn), (2016-2021)
Table 36. UCB S.A. Corporate Summary
Table 37. UCB S.A. Epileptic Seizures Treatment Product Offerings
Table 38. UCB S.A. Epileptic Seizures Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Pfizer, Inc. Corporate Summary
Table 40. Pfizer, Inc. Epileptic Seizures Treatment Product Offerings
Table 41. Pfizer, Inc. Epileptic Seizures Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Apotex, Inc. Corporate Summary
Table 43. Apotex, Inc. Epileptic Seizures Treatment Product Offerings
Table 44. Apotex, Inc. Epileptic Seizures Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Alexza Pharmaceuticals, Inc. Corporate Summary
Table 46. Alexza Pharmaceuticals, Inc. Epileptic Seizures Treatment Product Offerings
Table 47. Alexza Pharmaceuticals, Inc. Epileptic Seizures Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Neurelis, Inc. Corporate Summary
Table 49. Neurelis, Inc. Epileptic Seizures Treatment Product Offerings
Table 50. Neurelis, Inc. Epileptic Seizures Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Veriton Pharma Corporate Summary
Table 52. Veriton Pharma Epileptic Seizures Treatment Product Offerings
Table 53. Veriton Pharma Epileptic Seizures Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Epileptic Seizures Treatment Segment by Type
Figure 2. Epileptic Seizures Treatment Segment by Application
Figure 3. Global Epileptic Seizures Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Epileptic Seizures Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Epileptic Seizures Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epileptic Seizures Treatment Revenue in 2020
Figure 8. By Type - Global Epileptic Seizures Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Epileptic Seizures Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Epileptic Seizures Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Epileptic Seizures Treatment Revenue Market Share, 2016-2027
Figure 12. US Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Epileptic Seizures Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Epileptic Seizures Treatment Revenue Market Share, 2016-2027
Figure 24. China Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Epileptic Seizures Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Epileptic Seizures Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Epileptic Seizures Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Bausch Health Companies, Inc. Epileptic Seizures Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. GlaxoSmithKline plc. Epileptic Seizures Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. UCB S.A. Epileptic Seizures Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Pfizer, Inc. Epileptic Seizures Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Apotex, Inc. Epileptic Seizures Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Alexza Pharmaceuticals, Inc. Epileptic Seizures Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Neurelis, Inc. Epileptic Seizures Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)